Next Article in Journal
Asymptomatic Inflammatory Bowel Disease and Colorectal Cancer Screening Programs: How Common Is It and What Should be Done About It?
Previous Article in Journal
Correlation between Helicobacter pylori Infection and Gastric Atrophy Examined in the Sera of Mongolian People
Open AccessReview

Evidence of Differences and Discrimination in the Delivery of Care: Colorectal Screening in Healthy People and in the Care and Surveillance of Patients with Inflammatory Bowel Disease

by Afffa Farrukh 1,† and John F. Mayberry 2,*,†
1
Digestive Diseases Centre, University Hospitals of Leicester, Gwendolen Road, Leicester LE5 4PW, UK
2
Department of Digestive Diseases, Leicester General Hospital, Gwendolen Road, Leicester LE5 4PW, UK
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Gastrointest. Disord. 2019, 1(2), 253-260; https://doi.org/10.3390/gidisord1020020
Received: 27 February 2019 / Revised: 30 March 2019 / Accepted: 3 April 2019 / Published: 8 April 2019
Objectives: In this review the management of colorectal disease will be investigated as an exemplar of common practice in the UK in an attempt to identify factors responsible for the more general experiences of patients from ethnic minorities. Within this field such populations have a lower uptake of cancer screening programmes and their experience of day-to-day care for chronic gastrointestinal disorders is poor. Study design: PubMed and Google Scholar were reviewed in 2016 to identify publications concerning colorectal screening in patients with inflammatory bowel disease and healthy communities. Methods: Data were extracted from each paper and the references exploded to identify other potential reports. Results: It is reported that barriers exist both at individual and access levels but little has been done to overcome these. There have been a number of suggestions as to how to provide equitable access, but there is a clear need to ensure that these are evidence based and have been tested and shown to be effective in clinical trials. Conclusions: Clearly, current systems of surveillance and screening will only make a difference if they provide effective and acceptable services to all potential clients. Most programmes fail to address the specific risks and anxieties of minority groups, which are thought to be poorly compliant. This review considers those factors that may play a part and suggests approaches that could overcome these deficiencies. Some clues as to these factors may come from work with patients with chronic disorders. View Full-Text
Keywords: surveillance; screening; colon; inflammatory bowel disease; ethnicity; chronic disease surveillance; screening; colon; inflammatory bowel disease; ethnicity; chronic disease
MDPI and ACS Style

Farrukh, A.; Mayberry, J.F. Evidence of Differences and Discrimination in the Delivery of Care: Colorectal Screening in Healthy People and in the Care and Surveillance of Patients with Inflammatory Bowel Disease. Gastrointest. Disord. 2019, 1, 253-260.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Back to TopTop